\-\ Texto\\:\\ \ \(0\)\
\-\ sonographic\\ image\\ of\\ the\\ spleen\\ demonstrates\\ multiple\\ well\\-defined\\,\\ hyperechoic\\ lesions\\ within\\ the\\ splenic\\ parenchyma\\ with\\ a\\ similar\\ appearance\\ to\\ hepatic\\ hemangiomas\\.\ \(0\)\
\-\ splenic\\ hemangioma\ \(0\)\
\-\ hemangioma\\,\\ hamartoma\\,\\ angiosarcoma\\,\\ lymphoma\\,\\ metastatic\\ disease\\,\\ malignant\\ histiocytoma\\,\\ infection\\,\\ post\\-traumatic\\ hematomas\\,\\ lymphangiomas\ \(0\)\
\-\ 36\\ yo\\ female\\ with\\ persistant\\,\\ intermittent\\ left\\ shoulder\\ pain\\ \\(no\\ \ \(1\)\
\-\ injury\\)\\ x\\ 4\\ weeks\\.\\ pain\\ is\\ often\\ severe\\.\\ there\\ is\\ a\\ clinical\\ question\\ of\\ referred\\ pain\\.\\ the\\ patient\\ also\\ has\\ a\\ history\\ of\\ splenic\\ pathology\\ on\\ past\\ imaging\\ studies\\.\\ please\\ evaluate\\ spleen\\ and\\ gallbladder\\.\ \(0\)\
\-\ hemangiomas\\ are\\ benign\\ vascular\\ neoplasms\\ with\\ slow\\ internal\\ flow\\.\\ \\ \\ they\\ are\\ the\\ most\\ common\\ benign\\ neoplasms\\ of\\ the\\ spleen\\,\\ are\\ almost\\ always\\ asymptomatic\\ and\\,\\ as\\ in\\ this\\ case\\,\\ are\\ found\\ incidentally\\ on\\ imaging\\.\\ \\ \\ \\ hemangiomas\\ have\\ been\\ reported\\ in\\ up\\ to\\ 14\\%\\ of\\ autopsy\\ specimens\\.\\ \\ they\\ are\\ usually\\ a\\ solitary\\ solid\\ mass\\;\\ although\\,\\ they\\ can\\ be\\ diffuse\\ and\\ rarely\\ can\\ cause\\ splenomegaly\\.\\ \\ this\\ entity\\ has\\ also\\ been\\ described\\ in\\ the\\ klippel\\-trenaunay\\-weber\\ syndrome\\.\\ \\ they\\ do\\ not\\ usually\\ calcify\\.\\ \\ hamartomas\\,\\ also\\ benign\\ splenic\\ lesions\\ but\\ less\\ common\\,\\ may\\ demonstrate\\ some\\ calcification\\.\\ \\ distinguishing\\ between\\ these\\ two\\ benign\\ entities\\ is\\ often\\ difficult\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ splenic\\:\\ 0\\.08811168917981091\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.07598586946428597\ \(0\)\
\-\ spleen\\:\\ 0\\.06565729598271987\ \(0\)\
\-\ they\\:\\ 0\\.058646592885472505\ \(0\)\
\-\ benign\\:\\ 0\\.056172387943489555\ \(0\)\
\-\ neoplasms\\:\\ 0\\.041424860050589665\ \(0\)\
\-\ lymphangiomas\\:\\ 0\\.03674717207284947\ \(0\)\
\-\ hemangioma\\:\\ 0\\.03636482047811794\ \(0\)\
\-\ klippel\\-trenaunay\\-weber\\:\\ 0\\.035377257442126706\ \(0\)\
\-\ persistant\\:\\ 0\\.03151568498395371\ \(0\)\
\-\ hamartomas\\:\\ 0\\.029083182013639467\ \(0\)\
\-\ autopsy\\:\\ 0\\.028775855722508178\ \(0\)\
\-\ specimens\\:\\ 0\\.02848716704719182\ \(0\)\
\-\ distinguishing\\:\\ 0\\.02848716704719182\ \(0\)\
\-\ calcify\\:\\ 0\\.02821498412414445\ \(0\)\
\-\ entities\\:\\ 0\\.027957521165714566\ \(0\)\
\-\ are\\:\\ 0\\.027735092203085752\ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.0277132673829167\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.0277132673829167\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.026845069493421678\ \(0\)\
\-\ often\\:\\ 0\\.025966414747806213\ \(0\)\
\-\ hematomas\\:\\ 0\\.025626339140387394\ \(0\)\
\-\ entity\\:\\ 0\\.024914283264335185\ \(0\)\
\-\ usually\\:\\ 0\\.02471360241777866\ \(0\)\
\-\ also\\:\\ 0\\.024065994195287876\ \(0\)\
\-\ post\\-traumatic\\:\\ 0\\.023747033464178113\ \(0\)\
\-\ question\\:\\ 0\\.023349978183515963\ \(0\)\
\-\ hamartoma\\:\\ 0\\.02224944617892841\ \(0\)\
\-\ been\\:\\ 0\\.02214090370918087\ \(0\)\
\-\ slow\\:\\ 0\\.022027922294952727\ \(0\)\
\-\ lesions\\:\\ 0\\.021786290536609028\ \(0\)\
\-\ common\\:\\ 0\\.02129778297101331\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.02093656102938048\ \(0\)\
\-\ always\\:\\ 0\\.02093656102938048\ \(0\)\
\-\ \\,\\:\\ 0\\.020625528801317135\ \(0\)\
\-\ 36\\:\\ 0\\.020394852051491632\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.020343922103316644\ \(0\)\
\-\ solitary\\:\\ 0\\.02019432116887198\ \(0\)\
\-\ sonographic\\:\\ 0\\.0197270932833552\ \(0\)\
\-\ almost\\:\\ 0\\.019682796175439422\ \(0\)\
\-\ gallbladder\\:\\ 0\\.019552324869781736\ \(0\)\
\-\ rarely\\:\\ 0\\.019509616917482875\ \(0\)\
\-\ imaging\\:\\ 0\\.019067369756720028\ \(0\)\
\-\ can\\:\\ 0\\.018459260499705428\ \(0\)\
\-\ incidentally\\:\\ 0\\.018447028577891402\ \(0\)\
\-\ please\\:\\ 0\\.018055418586286773\ \(0\)\
\-\ 14\\:\\ 0\\.017931725793890293\ \(0\)\
\-\ difficult\\:\\ 0\\.01781116480348891\ \(0\)\
\-\ do\\:\\ 0\\.01766463309555199\ \(0\)\
\-\ intermittent\\:\\ 0\\.01746678070072879\ \(0\)\
\-\ parenchyma\\:\\ 0\\.017330327101869856\ \(0\)\
\-\ described\\:\\ 0\\.017330327101869856\ \(0\)\
\-\ hepatic\\:\\ 0\\.016992830246695297\ \(0\)\
\-\ pathology\\:\\ 0\\.016654278238677534\ \(0\)\
\-\ evaluate\\:\\ 0\\.016448696467890826\ \(0\)\
\-\ shoulder\\:\\ 0\\.016404192361137312\ \(0\)\
\-\ solid\\:\\ 0\\.016230222154792286\ \(0\)\
\-\ similar\\:\\ 0\\.015960412471147087\ \(0\)\
\-\ referred\\:\\ 0\\.015354911635503055\ \(0\)\
\-\ has\\:\\ 0\\.015282856861850267\ \(0\)\
\-\ studies\\:\\ 0\\.015197623417996001\ \(0\)\
\-\ pain\\:\\ 0\\.014908688107581924\ \(0\)\
\-\ reported\\:\\ 0\\.014833689764646725\ \(0\)\
\-\ calcification\\:\\ 0\\.014770407706938712\ \(0\)\
\-\ malignant\\:\\ 0\\.014707955601806197\ \(0\)\
\-\ less\\:\\ 0\\.01378066668725087\ \(0\)\
\-\ cause\\:\\ 0\\.013767917269295079\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.013755201895219464\ \(0\)\
\-\ although\\:\\ 0\\.013742520383698114\ \(0\)\
\-\ internal\\:\\ 0\\.013642266054184627\ \(0\)\
\-\ flow\\:\\ 0\\.013447875604088173\ \(0\)\
\-\ x\\:\\ 0\\.013424125406416559\ \(0\)\
\-\ vascular\\:\\ 0\\.013341920323446176\ \(0\)\
\-\ injury\\:\\ 0\\.012972421628041906\ \(0\)\
\-\ past\\:\\ 0\\.01292952129498302\ \(0\)\
\-\ between\\:\\ 0\\.01289759779154402\ \(0\)\
\-\ found\\:\\ 0\\.012823931497391012\ \(0\)\
\-\ image\\:\\ 0\\.012710424601417148\ \(0\)\
\-\ severe\\:\\ 0\\.012520522857457164\ \(0\)\
\-\ clinical\\:\\ 0\\.012520522857457164\ \(0\)\
\-\ some\\:\\ 0\\.01235680120888933\ \(0\)\
\-\ diffuse\\:\\ 0\\.012319082954168167\ \(0\)\
\-\ yo\\:\\ 0\\.012244531063346487\ \(0\)\
\-\ infection\\:\\ 0\\.011828650352727654\ \(0\)\
\-\ two\\:\\ 0\\.011653958274361933\ \(0\)\
\-\ appearance\\:\\ 0\\.011637650365403056\ \(0\)\
\-\ syndrome\\:\\ 0\\.011637650365403056\ \(0\)\
\-\ lymphoma\\:\\ 0\\.011629517306616599\ \(0\)\
\-\ weeks\\:\\ 0\\.011548941699529278\ \(0\)\
\-\ 4\\:\\ 0\\.01133796145323355\ \(0\)\
\-\ up\\:\\ 0\\.010942129290734398\ \(0\)\
\-\ these\\:\\ 0\\.010589736628370669\ \(0\)\
\-\ metastatic\\:\\ 0\\.010243378112457574\ \(0\)\
\-\ \\;\\:\\ 0\\.00964486280215521\ \(0\)\
\-\ \\%\\:\\ 0\\.009492004920695275\ \(0\)\
\-\ most\\:\\ 0\\.009394453055847981\ \(0\)\
\-\ demonstrate\\:\\ 0\\.009364057815871624\ \(0\)\
\-\ this\\:\\ 0\\.009153687745848887\ \(0\)\
\-\ may\\:\\ 0\\.008925373185229162\ \(0\)\
\-\ case\\:\\ 0\\.008902402061272718\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008888672388824697\ \(0\)\
\-\ have\\:\\ 0\\.008811609896976628\ \(0\)\
\-\ but\\:\\ 0\\.00867858714777875\ \(0\)\
\-\ multiple\\:\\ 0\\.00857050477847271\ \(0\)\
\-\ female\\:\\ 0\\.008365525102132542\ \(0\)\
\-\ is\\:\\ 0\\.00803272540549608\ \(0\)\
\-\ within\\:\\ 0\\.007762530516124199\ \(0\)\
\-\ a\\:\\ 0\\.00755428193940193\ \(0\)\
\-\ on\\:\\ 0\\.006894200117765982\ \(0\)\
\-\ disease\\:\\ 0\\.006651131148646211\ \(0\)\
\-\ be\\:\\ 0\\.0062750320159234724\ \(0\)\
\-\ as\\:\\ 0\\.006155130980448228\ \(0\)\
\-\ there\\:\\ 0\\.006055788364118994\ \(0\)\
\-\ in\\:\\ 0\\.00601996043057507\ \(0\)\
\-\ not\\:\\ 0\\.005880088913056835\ \(0\)\
\-\ mass\\:\\ 0\\.005659338128321736\ \(0\)\
\-\ history\\:\\ 0\\.005620069227176588\ \(0\)\
\-\ left\\:\\ 0\\.004552882234632928\ \(0\)\
\-\ no\\:\\ 0\\.004097353098589534\ \(0\)\
\-\ patient\\:\\ 0\\.004079009194839943\ \(0\)\
\-\ to\\:\\ 0\\.004067315318504632\ \(0\)\
\-\ the\\:\\ 0\\.003949979562960737\ \(0\)\
\-\ \\(\\:\\ 0\\.0034398177440183838\ \(0\)\
\-\ \\)\\:\\ 0\\.0033977985338728817\ \(0\)\
\-\ of\\:\\ 0\\.0027739000189997243\ \(0\)\
\-\ and\\:\\ 0\\.002571557224745978\ \(0\)\
\-\ \\.\\:\\ 0\\.002366635739823085\ \(0\)\
\-\ with\\:\\ 0\\.0016714882298555676\ \(0\)\
